China SXT Pharmaceuticals (SXTC) Current Assets: 2018-2025
- China SXT Pharmaceuticals' Current Assets rose 18.44% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 18.44%. This contributed to the annual value of $21.3 million for FY2025, which is 49.62% up from last year.
- According to the latest figures from Q3 2025, China SXT Pharmaceuticals' Current Assets is $26.0 million, which was up 22.28% from $21.3 million recorded in Q1 2025.
- China SXT Pharmaceuticals' 5-year Current Assets high stood at $26.0 million for Q3 2025, and its period low was $11.7 million during Q3 2021.
- In the last 3 years, China SXT Pharmaceuticals' Current Assets had a median value of $20.4 million in 2023 and averaged $19.4 million.
- Its Current Assets has fluctuated over the past 5 years, first tumbled by 47.14% in 2021, then spiked by 62.93% in 2024.
- China SXT Pharmaceuticals' Current Assets (Quarterly) stood at $11.7 million in 2021, then grew by 5.99% to $12.4 million in 2022, then climbed by 9.19% to $13.5 million in 2023, then soared by 62.93% to $22.0 million in 2024, then grew by 18.44% to $26.0 million in 2025.
- Its Current Assets stands at $26.0 million for Q3 2025, versus $21.3 million for Q1 2025 and $22.0 million for Q3 2024.
